Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
297 studies found for:    Open Studies | Bladder cancer
Show Display Options
Rank Status Study
1 Recruiting Biomarker Identification for Bladder Cancer Patients
Condition: Bladder Cancer
Intervention: Procedure: Sample Collection
2 Recruiting Pembrolizumab With Chemoradiotherapy as Treatment for Muscle Invasive Bladder Cancer
Condition: Bladder Cancer
Interventions: Drug: Pembrolizumab;   Drug: Cisplatin;   Radiation: Radiotherapy
3 Recruiting Radiation Therapy and Chemotherapy in Treating Patients With Stage I Bladder Cancer
Condition: Bladder Cancer
Interventions: Drug: cisplatin;   Drug: fluorouracil;   Drug: mitomycin C
4 Recruiting Celecoxib With Chemotherapy in Localized, Muscle-Invasive Bladder Cancer
Condition: Bladder Cancer
Interventions: Drug: Celecoxib;   Drug: Gemcitabine;   Drug: Cisplatin
5 Not yet recruiting Radiation Therapy and Durvalumab, With or Without Tremelimumab, in Patients With Bladder Cancer
Condition: Bladder Cancer
Interventions: Drug: Durvalumab;   Drug: Tremelimumab;   Radiation: Radiation Therapy
6 Recruiting Enzalutamide for Bladder Cancer Chemoprevention
Condition: Bladder Cancer
Intervention: Drug: Enzalutamide
7 Recruiting VPM1002BC in Recurrent Non-muscle Invasive Bladder Cancer
Condition: Bladder Cancer
Intervention: Drug: VPM1002BC
8 Recruiting Investigating Bladder Chemotherapy Instead of Surgery for Low Risk Bladder Cancer
Condition: Bladder Cancer
Interventions: Drug: Mitomycin C;   Procedure: Surgical Management
9 Recruiting Metformin and Simvastatin Use in Bladder Cancer
Condition: Bladder Cancer
Interventions: Drug: Metformin;   Drug: Simvastatin
10 Recruiting MRI in Clinical Staging and Estimation of Treatment Response in Bladder Cancer
Condition: Bladder Cancer
Intervention: Device: MR imaging
11 Recruiting A Study of Blue Light Flexible Cystoscopy With Cysview in the Detection of Bladder Cancer in the Surveillance Setting
Condition: Bladder Cancer
Interventions: Drug: Hexaminolevulinate hydrochloride;   Device: KARL STORZ D-Light C PDD Flexible Videoscope System
12 Recruiting Risk of Bladder Cancer in Type 2 Diabetes Patients With Pioglitazone Therapy "PROBE"
Condition: Bladder Cancer
Intervention: Drug: Pioglitazone
13 Recruiting MK-3475/BCG in High Risk Superficial Bladder Cancer
Condition: Bladder Cancer
Intervention: Drug: Intravenous MK-3475/ Intravesical BCG
14 Recruiting PET/MRI and Biomarkers in Bladder Cancer
Condition: Bladder Cancer
Intervention: Device: MRI/acetate-PET imaging
15 Recruiting Fluorescence Cystoscopy and Optimized MMC in Recurrent Bladder Cancer (FinnBladder 9)
Condition: Bladder Cancer
Interventions: Procedure: white light TUR-BT;   Procedure: blue light TUR-BT;   Drug: optimized MMC;   Drug: single immediate chemotherapy instillation
16 Recruiting Evaluation the Treatment of Tamoxifen of Low/Intermediate Risk Bladder Tumors
Condition: Bladder Cancer
Intervention: Drug: Tamoxifen Citrate
17 Recruiting Genetic Susceptibility to Bladder Cancer
Condition: Bladder Cancer
Intervention: Behavioral: Interviews
18 Recruiting Improving Clinical Staging for Muscle Invasive Bladder Cancer Through Molecular Profiling and Improved Imaging
Condition: Bladder Cancer
Interventions: Procedure: Tissue Biopsy;   Procedure: Magnetic Resonance Imaging (MRI)
19 Recruiting Laser En Bloc Resection Of Bladder Tumor (HoLERBT) VS. Conventional Transurethral Resection Of Bladder Tumors (cTURBT)
Condition: Bladder Cancer
Interventions: Device: HoLERBT;   Device: cTURBT
20 Recruiting S1314, Co-expression Extrapolation (COXEN) Program to Predict Chemotherapy Response in Patients With Bladder Cancer
Condition: Bladder Cancer
Interventions: Drug: Gemcitabine;   Drug: Cisplatin;   Drug: Methotrexate;   Drug: Vinblastine;   Drug: Doxorubicin;   Drug: Filgrastim

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.